What's happening
This bill expands the scope of restricted clinical laboratory licenses in New York to include molecular testing and toxicology.
Why it matters
Expanding restricted laboratory licenses to include "molecular testing" and "toxicology" means more laboratory professionals may legally perform advanced testing methods, potentially speeding up patient diagnoses and access to modern treatments.
The changes allow certain specialized labs (like cancer centers and teaching hospitals) to include a broader range of molecular testing—beyond just genetic/molecular oncology—so these facilities can offer more comprehensive diagnostic services without needing additional licensing.
By explicitly listing toxicology, the law responds to public health needs such as opioid and drug monitoring, allowing more professionals to support substance abuse treatment, forensic work, and workplace drug testing.
Broader licensure eligibility could help address workforce shortages in clinical labs, ensuring timely processing of increasingly complex tests that are vital for personalized medicine and public health surveillance.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Restricted clinical laboratory licensees
The bill would broaden the molecular work their certificates may authorize by replacing molecular diagnosis limited to genetic testing-molecular and molecular oncology with molecular testing.
Clinical laboratories
The bill would expand the molecular testing work that appropriately certified restricted licensees could perform.
National Cancer Institute-designated cancer centers and eligible teaching hospitals
The bill would update their restricted-license certificate provisions to refer to molecular testing rather than molecular diagnosis, while retaining site restrictions for additional practice areas.
State Education Department
The bill would change the scope of molecular work it may authorize through restricted clinical laboratory licenses and certificates.
Headline styles
Expand Lab License Scope
Plain English, a few words. Used as the page title.
Sponsors
1 Co-sponsor
History
- Substituted by S7527
- Rules report cal.896
- Reported
- Reported referred to rules
- Reference changed to ways and means
- Referred to higher education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Expand Lab License Scope
Signed by Governor · Sponsor Iwen Chu
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7724
2023-2024 Regular Sessions
IN ASSEMBLY
June 6, 2023
Introduced by M. of A. CLARK -- read once and referred to the Committee on Higher Education
AN ACT to amend the education law, in relation to restricted clinical laboratory licenses
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraphs (a) and (b) of subdivision 1 of section 8610 of the education law, as amended by chapter 227 of the laws of 2019, are amended to read as follows:
(a) The department may issue a restricted license pursuant to which the restricted licensee may receive a certificate to perform certain examinations and procedures within the definition of clinical laboratory technology set forth in subdivision one of section eighty-six hundred one of this article, provided that such a restricted licensee may perform examinations and procedures only in those of the following areas which are specifically listed in his or her certificate: histocompatibility, cytogenetics, stem cell process, flow cytometry/cellular immunology [and molecular diagnosis to the extent such molecular diagnosis is included in genetic testing-molecular and molecular oncology], molecular testing, and toxicology (under paragraph (b-1) of this subdivision).
(b) Notwithstanding paragraph (a) of this subdivision, restricted licensees employed at National Cancer Institute designated cancer centers or at teaching hospitals that are eligible for distributions pursuant to paragraph (c) of subdivision three of section twenty-eight hundred seven-m of the public health law may receive a certificate that also includes the practice of molecular [diagnosis] testing including but not limited to genetic testing-molecular and molecular oncology, and restricted licensees employed at national cancer institute designated cancer centers may receive a certificate that includes the use of mass spectrometry or any tests and procedures acceptable to the commissioner
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD11731-01-3
of health, in consultation with the commissioner, in the field of proteomics, provided that such certificate holders may practice in such additional areas only at such centers, teaching hospitals or other sites as may be designated by the commissioner.
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.